{
"NDC": {
"NDCCode": "71921-410-72",
"PackageDescription": "1 BOTTLE in 1 CARTON (71921-410-72) / 300 mL in 1 BOTTLE",
"NDC11Code": "71921-0410-72",
"ProductNDC": "71921-410",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Brivaracetam Oral Solution",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Brivaracetam Oral",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20260224",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA220385",
"LabelerName": "Florida Pharmaceutical Products, LLC",
"SubstanceName": "BRIVARACETAM",
"StrengthNumber": "10",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Epoxide Hydrolase Inhibitors [MoA]",
"DEASchedule": "CV",
"Status": "Active",
"LastUpdate": "2026-02-25",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260224",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}